HeliyonNeurosciencePeer-reviewed journal article
Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons
Alessandro FiorenzanoiD, Marcella BirteleiD, Jenny Nelander Wahlestedt, Malin ParmariD
Abstract
The focal and progressive degeneration of dopaminergic (DA) neurons in ventral midbrain has made Parkinson's disease (PD) a particularly interesting target of cell-based therapies. However, ethical issues and limited tissue availability have so far hindered the widespread use of human fetal tissue in cell-replacement therapy. DA neurons derived from human pluripotent stem cells (hPSCs) offer unprecedented opportunities to access a renewable source of cells suitable for PD therapeutic applications. To better understand the functional properties of stem-cell derived DA neurons, we generated targeted hPSC lines with the gene coding for Cre recombinase knocked into the TH locus. When combined with flexed GFP, they serve as reporter cell lines able to identify and isolate TH+ neurons in vitro and after transplantation in vivo. These TH-Cre lines provide a valuable genetic tool to manipulate DA neurons useful for the design of more precise DA differentiation protocols and the study of these cells after transplantation in pre-clinical animal models of PD.Competing Interest StatementThe authors have declared no competing interest.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 12
- FWCI
- 0.63
- Field percentile
- top 40%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TNF-NFkB-p53 axis restricts in vivo survival of hPSC-derived dopamine neuron
Tae Wan Kim, So Yeon Koo, … Lorenz Studer·CellPeer-reviewed·Jun 11, 2024
- Human embryonic stem cells-derived dopaminergic neurons transplanted in parkinsonian monkeys recover dopamine levels and motor behavior
Adolfo López-Ornelas, Itzel Escobedo-Ávila, … Iván Velasco·bioRxiv·Jul 8, 2020
- Transcription factor-mediated generation of dopaminergic neurons from human iPSCs: a comparison of methods
Kirstin O. McDonald, Nikita M. A. Lyons, … Indranil Basak·CellsPeer-reviewed·Jun 11, 2024
- Single Cell Gene Expression Analysis Reveals Human Stem Cell-Derived Graft Composition in a Cell Therapy Model of Parkinson’s Disease
Katarína Tiklová, Sara Nolbrant, … Malin Parmar·bioRxiv·Aug 5, 2019
- Enhanced Production of Mesencephalic Dopaminergic Neurons from Lineage-Restricted Human Undifferentiated Stem Cells
Muyesier Maimaitili, Muwan Chen, … Mark Denham·Nature CommunicationsPeer-reviewed·Dec 5, 2023
- Human stem cell transplantation for Parkinson's disease: A systematic review of in situ survival and maturation of progenitors derived from human embryonic or induced stem cells in Parkinsonian models.
Giulia Comini, Eilís Dowd·bioRxiv·Mar 28, 2024